In the tumor microenvironment, NK cells display higher expression of PD-1, and PD-1/PD-L1 blockade might therefore reverse the dysfunctional status of NK cells in this context, adding to the benefits of enhanced T cell responses upon PD-1/PD-L1 blockade9. This evidence concerns the gene PDCD1 and neoplasm.